Metabolic Reset

This page sets out which two pens the Metabolic Reset stack contains, what the 12% bundle saving covers, and what documentation Veyvora provides before dispatch, so you can confirm pricing before ordering.

Ready to order? Confirm current GBP pricing and stock at veyvora.com/peptides/stacks/metabolic-reset.

The Metabolic Reset Research Pen Stack is a two-pen bundle from Veyvora’s Metabolic & Weight range, comprising MOTS-C + SS-31 40 and Tirzepatide 40, sold at 12% below individual pen prices (Veyvora, 2026). A numeric GBP price and current stock level are not published in the available page text; confirm both directly with Veyvora before ordering[1].

Last updated: 30 August 2026.

Key Takeaways

• The Metabolic Reset stack contains exactly two pens: MOTS-C + SS-31 40 (mitochondrial function) and Tirzepatide 40 (dual GIP/GLP-1 agonism), both in pre-filled 3 mL, 300-click format.
• The bundle saves 12% versus purchasing each pen individually; the exact GBP figure must be confirmed at checkout.
• Every pen is independently assayed before dispatch; no combined-assay or co-administration data is published for the stack.
• Supply is for laboratory research use only, not for human or veterinary use.

Advanced Metabolic Reset, Bundle Contents at a Glance

The table below covers the Advanced Metabolic Reset (three-pen configuration), which sits one tier above the Metabolic Reset in Veyvora’s stack catalogue[1].

Source: Veyvora stack catalogue, 30 August 2026[1].

Price Block, Metabolic Reset Pen Stack

Every pen in the Metabolic Reset stack is independently assayed before dispatch. The stack is supplied for laboratory research use only and is not for human or veterinary use.

The Metabolic Reset Research Pen Stack contains two verified pens, MOTS-C + SS-31 40 and Tirzepatide 40, both in pre-filled 3 mL, 300-click multi-dose format (Veyvora, 2026).

Source: Veyvora Metabolic Reset stack page and Tirzepatide 40 product page, 30 August 2026[1].

Veyvora describes MOTS-C + SS-31 40 as a mitochondrial blend targeting cellular energy pathways. Researchers requiring compound-level context on the two mitochondrial agents can review the MOTS-C and SS-31 comparison before selecting the combined format. Accessory inclusion at bundle level — needles, dosing card — is confirmed only for the individual Tirzepatide 40 product page and is unverified for the stack as a whole; confirm with Veyvora before ordering.

Published research documents activity for each compound individually, though controlled studies examining combined use remain limited. The Metabolic Reset stack does not include Retatrutide 40 or NAD+ 1000; those compounds appear in sibling configurations such as the Advanced Metabolic Reset[1].

Veyvora publishes a CoA for Tirzepatide 40 on request and states that buyers can verify your batch against its CoA before first use. No batch-specific assay file appears directly on the Metabolic Reset stack page, so stack-level batch traceability details are unverified unless separately provided at order level[1].

The table below maps each documentation and handling claim to its verified status as of 30 August 2026.

Source: Veyvora Metabolic Reset stack page and Tirzepatide 40 product page, 30 August 2026.

HPLC (high-performance liquid chromatography) purity testing confirms compound identity and concentration within a defined tolerance. A CoA result alone does not establish efficacy or safety, so what HPLC purity does and does not prove is covered separately and should be read before drawing analytical conclusions. Confirm current batch documentation availability directly with Veyvora at the point of order, as stack-level combined assay statements are absent from the retrieved source text[1].

The Metabolic Reset Research Pen Stack is supplied by Veyvora for laboratory research use only and is not for human or veterinary use. The compounds are not medicines and are not authorised for administration to humans or animals under any circumstances stated on the product page[1].

What This Means for Procurement and Analytical Use

Researchers sourcing the Metabolic Reset stack must ensure all intended applications remain within in-vitro and laboratory research contexts. The research-use-only designation is a seller-imposed supply restriction, not an MHRA (Medicines and Healthcare products Regulatory Agency) marketing authorisation or equivalent regulatory approval; no such authorisation appears in the retrieved page content[1].

The following restrictions apply as stated by Veyvora as of 30 August 2026[1]:

• Not for human consumption
• Not for veterinary use
• Not classified as a medicine
• No treatment, dosing, or clinical protocol claims are supported by the product listing
• No human outcome data is published at stack or bundle level

Confirm the batch number against the CoA available on request before first use. Consult Veyvora’s storage and stability guidance for post-receipt handling requirements. Researchers comparing the stack’s tirzepatide component with catalogue alternatives can review the Retatrutide versus Tirzepatide comparison before placing an order.

To confirm current GBP pricing, stock availability, and shipping terms for the Metabolic Reset stack, visit the product page directly at veyvora.com/peptides/stacks/metabolic-reset.